Rapidly Advancing New Scientific Discoveries
to Transform the Way Cancer is Treated Using RNA
|
TransCode is developing RNA therapeutics for the treatment of several tumor indications with its initial focus on tackling one of the most feared stages of cancer -- cancer progression or metastasis.
|
|
Click on the animation above to see how our lead candidate therapeutic works
|
Power and Potential of RNA-based TherapiesThe power of RNA therapeutics lies in their ability to target any gene which enables rational and straightforward drug design. RNA-based therapeutics are highly selective to their targets, potentially making available a broad array of previously undruggable targets in cancer including metastasis.
|
TransCode Therapeutics believes it has overcome the barrier to harnessing
RNA technology for cancer treatment — delivery of RNA therapeutics to cancer cells
A small, non-coding microRNA called miRNA-10b, is shown to be the master regulator of metastasis in a range of solid tumors
Metastatic tumor cells are better equipped to safely travel to other parts of the body and develop metastases in organs different from the organ of origin
|
Cells in the primary tumor are known to upregulate miRNA-10b which allows metastatic cells to develop, detach, and migrate
TransCode’s TTX platform has the potential to treat a variety of
tumor indications through effective delivery and targeting |